Heart and Vascular Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Richard and Susan Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical, Harvard Medical School, Boston, Massachusetts.
JAMA Cardiol. 2018 Dec 1;3(12):1222-1225. doi: 10.1001/jamacardio.2018.3951.
The US News & World Report (USNWR) identifies the "Best Hospitals" for "Cardiology and Heart Surgery." These rankings may have significant influence on patients and hospitals.
To determine whether USNWR top-ranked hospitals perform better than nonranked hospitals on mortality rates and readmission measures as well as patient satisfaction.
DESIGN, SETTING, AND PARTICIPANTS: This national retrospective study evaluated outcomes at 3552 US hospitals from 2014 to 2017.
US News & World Report 2018 to 2019 Cardiology and Heart Surgery rankings (top-ranked vs nonranked hospitals).
Hospital-level 30-day risk-standardized mortality and readmission rates for Medicare fee-for-service beneficiaries age 65 years or older hospitalized for 3 cardiovascular conditions: acute myocardial infarction (AMI), heart failure (HF), and coronary artery bypass grafting (CABG) as well as Hospital Consumer Assessment of Healthcare Providers and Systems patient satisfaction star ratings obtained from publicly available Centers for Medicaid and Medicare Services data.
Thirty-day mortality rates at top-ranked hospitals (n = 50), compared with nonranked hospitals (n = 3502), were lower for AMI (11.9% vs 13.2%, P < .001), HF (9.5% vs 11.9%; P < .001), and CABG (2.3%vs 3.3%; P < .001). Thirty-day readmission rates at the top-ranked hospitals (n = 50) when compared with nonranked hospitals (n = 2841) were similar for AMI (16.7% vs 16.5%; P = .64) and CABG (14.1% vs 13.7%; P = .15) but higher for HF (21.0% vs 19.2%; P < .001), Finally, patient satisfaction was higher at top-ranked hospitals (n = 50) compared with nonranked hospitals (n = 3412) (3.9 vs 3.3; P < .001).
We found that USNWR top-ranked hospitals for cardiovascular care had lower 30-day mortality rates for AMI, HF, and CABG and higher patient satisfaction ratings compared with nonranked hospitals. However, 30-day readmission rates were either similar (for AMI and CABG) or higher (for HF) at top-ranked compared with nonranked hospitals. This discrepancy between readmissions and other performance measures raises concern that readmissions may not be an adequate metric of hospital care quality.
《美国新闻与世界报道》(USNWR)评选出了“心脏病学和心脏外科”的“最佳医院”。这些排名可能对患者和医院产生重大影响。
确定 USNWR 顶级医院在死亡率和再入院率以及患者满意度方面是否优于未排名医院。
设计、地点和参与者:这是一项全国性的回顾性研究,评估了 2014 年至 2017 年期间 3552 家美国医院的结果。
2018 年至 2019 年《美国新闻与世界报道》心脏病学和心脏外科排名(顶级排名与非排名医院)。
65 岁及以上因 3 种心血管疾病(急性心肌梗死(AMI)、心力衰竭(HF)和冠状动脉旁路移植术(CABG)住院的 Medicare 按服务收费的患者的 30 天风险标准化死亡率和再入院率,以及从公开的医疗补助和医疗保险服务数据中获得的医院消费者评估医疗保健提供者和系统患者满意度星级评分。
顶级医院(n=50)与非排名医院(n=3502)相比,AMI(11.9%比 13.2%,P<0.001)、HF(9.5%比 11.9%,P<0.001)和 CABG(2.3%比 3.3%,P<0.001)的 30 天死亡率较低。顶级医院(n=50)与非排名医院(n=2841)相比,AMI(16.7%比 16.5%,P=0.64)和 CABG(14.1%比 13.7%,P=0.15)的 30 天再入院率相似,但 HF(21.0%比 19.2%,P<0.001)的再入院率较高。最后,顶级医院(n=50)的患者满意度高于非排名医院(n=3412)(3.9 比 3.3,P<0.001)。
我们发现,美国心血管护理的 USNWR 顶级医院的 AMI、HF 和 CABG 的 30 天死亡率较低,患者满意度较高,而非排名医院则较低。然而,顶级医院的 30 天再入院率与非排名医院相比,要么相似(AMI 和 CABG),要么更高(HF)。再入院率与其他绩效指标之间的这种差异引起了人们的关注,即再入院率可能不是衡量医院护理质量的充分指标。